About SpringWorks Therapeutics:
SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors.
We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).
At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.
Your Role:
The Director, Value, Access & Pricing (VAP) GOMEKLI is a critical leadership role within the U.S. Market Access team, responsible for shaping the strategic direction and leading the development and execution of market access and pricing strategies to support the commercial success of GOMEKLI.
This individual will lead the development of access strategies and tactics that communicate the differentiated value of GOMEKLI to key external stakeholders—including payers, C-suite executives, provider networks, GPOs, pharmacists, and population-based decision-makers in community oncology. The Director will be accountable for delivering a suite of payer and provider-facing tools, field team resources, and non-personal engagement tactics to ensure optimal access and uptake.
The Director will collaborate closely with cross-functional partners including brand marketing, sales, HEOR, medical affairs, patient services, and operations to ensure strategic alignment and execution excellence. This position reports to the Executive Director, Value, Access & Pricing – Rare Tumors and works in close partnership with the broader U.S. Market Access.
This role is open for remote consideration #LI-Remote
This role is preferred hybrid: work onsite 3 days a week at our Seaport office
Essential Duties and Responsibilities:
- Act as the product-specific market access expert and central hub for all access-related topics, serving as the primary point of contact for cross-functional teams and informing the broader U.S. Market Access organization on product-specific developments, strategies, and insights
- Leads the development of Market Access strategies and evidence-based payor value proposition; manages the execution of brand aligned Market Access tactical plans that influence coverage decisions and remove patient access hurdles
- Leads strategic and tactical development and pull through of various field-based resources to support field facing teams including Strategic Enterprise Account Directors (SEADs), Field Access Managers (FAMs), and Sales teams
- Shapes the development of pricing and contracting strategies, ensuring market competitiveness, payor acceptance and coverage policies that enable patient access
- Manage Pricing and Government Pricing annual lifecycle, including both strategic and operational activities to maintain compliance with regulations
- Continuously evaluates changing market and competitive dynamics to inform short and long-term strategies including but not limited to formulary positioning, contracting, pricing, real-world evidence generation and public policy
- Leads the management of key strategic partner relationships to ensure execution of the strategic vision and tactical goals as well as the timely completion of projects within budget
- Monitor evolving reimbursement and policy landscape and integrate insights into access strategy
- Measure and report impact of targeted launch / access tactical plan investments
Role Requirements:
Education:
- Bachelor's degree (business or related disciplines)
- MBA or other advanced degree preferred
Skills/Experience:
- 9+ years of pharmaceutical and/or biotech experience required in rare disease or Oncology
- 5+ years in internal Market access role
- Internal rare disease/oncology launch experience required (strategic, operational and tactical)
- Inline rare disease/oncology product market access and cross-functional brand team experience required
- Value/payer marketing and customer insights generation experience required
- Field and/or field payer experience preferred
- New Product Pricing experience preferred
- Understanding of Oncology value frameworks, HeOR, pricing, policy and patient advocacy preferred
- Experience in patient administered products (Part D, oral)
- Experience working a collaborative, dynamic, accountable environment
Technical:
- Expert in US market access environment with knowledge of recent policy changes, external product launches and current dynamics in Rare & Oncology
Other:
- Collaborative and curious, with innovative drive and continuous improvement mindset
- Ability to travel to market access internal and external customer-facing meetings 30-40%
Leadership:
- Inclusive, humble, people-first leader with demonstrated examples of successful collaboration and engagement in a fast-moving environment
Communication:
- Strong communication both written and verbal
- Ability to influence up and across to achieve strategic objectives, gain alignment and secure resources
Preferred Qualifications:
- Ability to communicate openly and share information to foster trust while encouraging constructive debate, making informed decisions, and ensuring shared commitment to outcomes.
- Demonstrated willingness to take risks and stand up for what is right while prioritizing the needs and experiences of customers and patients in all decisions.
- Commitment to setting and reaching ambitious goals and setting high standards while acting in the best interest of the company and taking initiative to drive results.
- Uphold ethical standards and being honest in all interactions.
- Ability to streamline processes to focus on what matters and creates impact and acting quickly to adapt to changes.
- Demonstrated ability to embrace new ideas, challenge the status quo, and seek innovative solutions while valuing diverse perspectives and treating others with respect and dignity.
Compensation and Benefits:
The expected salary range for this position is $167,000 – $270,000. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.
We offer best-in-class benefits for our team of SpringWorkers who work with urgency on behalf of patients suffering from devastating diseases. Interested in learning more, review additional information here Benefits.
EEO Statement:
SpringWorks maintains an EEO Policy providing for equitable opportunities for employment and conditions of employment to all employees and applicants regardless of actual or perceived sex (including pregnancy, childbirth, breastfeeding or related medical conditions), gender, gender identity or gender expression, sexual orientation, partnership status, marital status, familial status, pregnancy status, race, color, national origin, ancestry, caste, religion, religious creed, age, alienage or citizenship status, veteran status, military status, physical or mental disability, past or present history of mental disorder, medical condition, AIDS/HIV status, sickle cell or hemoglobin C trait, genetic predisposition, genetic information, protected medical leaves, victims of domestic violence, stalking, or sex offense, political affiliation and any and all other characteristics or categories protected by applicable federal, state or local laws. SpringWorks treats all employees and applicants fairly in the selection process (and in other personnel activities) by giving all employees and applicants the same opportunities for employment. SpringWorks’ Equal Employment Opportunity Policy is intended to ensure that there are no barriers that would prevent members of a protected group from a fair and equitable opportunity to be hired, promoted, or to otherwise take advantage of employment opportunities.
This Equal Employment Opportunity Policy applies to all aspects of employment, including, without limitation, recruitment, hiring, placement, job assignment, promotion, termination, transfer, leaves of absence, compensation, discipline, and access to benefits and training. Any violation of this Policy will result in disciplinary action up to and including termination of employment.
Privacy:
Upon submission of this form I understand that SpringWorks Therapeutics is based in the United States and personal data submitted in the form will be transferred and accessed in the U.S.. Information about SpringWorks Therapeutics’ privacy practices can be found at Privacy Policy - Springworks (springworkstx.com).
Skills Required
- Bachelor's degree (business or related disciplines)
- MBA or other advanced degree
- 9+ years pharmaceutical and/or biotech experience in rare disease or oncology
- 5+ years in an internal market access role
- Internal rare disease/oncology launch experience (strategic, operational, tactical)
- Inline rare disease/oncology product market access and cross-functional brand team experience
- Value/payer marketing and customer insights generation experience
- Field and/or field payer experience
- New product pricing experience
- Understanding of oncology value frameworks, HEOR, pricing, policy and patient advocacy
- Experience with patient-administered products (Part D, oral)
- Expert knowledge of US market access environment and recent policy/launch dynamics
- Ability to travel to customer-facing meetings 30-40%
- Strong written and verbal communication and ability to influence cross-functionally
What We Do
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers
